MLH1 V384D
|
NSCLC
|
MLH1 V384D
|
NSCLC
|
erlotinib Sensitive: C3 – Early Trials
|
erlotinib Sensitive: C3 – Early Trials
|
MLH1 V384D
|
NSCLC
|
MLH1 V384D
|
NSCLC
|
gefitinib Sensitive: C3 – Early Trials
|
gefitinib Sensitive: C3 – Early Trials
|
MLH1 V384D
|
NSCLC
|
MLH1 V384D
|
NSCLC
|
icotinib Sensitive: C3 – Early Trials
|
icotinib Sensitive: C3 – Early Trials
|